DrugPatentWatch Database Preview
Biologic Drugs With Ingredient Type: Alkaline Phosphatase
» See Plans and Pricing
Biologic Drugs With Ingredient Type: Alkaline Phosphatase
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 001 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 001 | 2015-10-23 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 002 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 002 | 2015-10-23 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 003 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 003 | 2015-10-23 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 004 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
